Chinese Journal of Cancer Research

Papers
(The TQCC of Chinese Journal of Cancer Research is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Esophageal cancer: Epidemiology, risk factors and screening66
Screening for gastric cancer in China: Advances, challenges and visions48
Colorectal cancer burden and trends: Comparison between China and major burden countries in the world42
Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study40
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version)30
Mn-based cGAS-STING activation for tumor therapy25
Update in version 2021 of CSCO guidelines for colorectal cancer from version 202025
Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review24
CSCO guidelines for colorectal cancer version 2022: Updates and discussions22
Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−203022
Burden of liver cancer: From epidemiology to prevention20
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)18
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)16
Lung cancer risk in never-smokers: An overview of environmental and genetic factors15
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)15
Surgical treatment of gastric cancer: Current status and future directions15
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression14
Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing13
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)12
Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer12
Features of colorectal cancer in China stratified by anatomic sites: A hospital-based study conducted in university-affiliated hospitals from 2014 to 201811
Current status of lymph node dissection in gastric cancer11
Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer10
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns10
Inducing immunogenic cell death in immuno-oncological therapies10
Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics10
Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma10
Prognostic value of a modified Immunosocre in patients with stage I−III resectable colon cancer9
A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy8
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial8
Current status and future perspectives on neoadjuvant therapy in gastric cancer8
Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts8
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)8
Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer8
Open surgery in the era of minimally invasive surgery8
Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress8
Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008−20178
National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China (English version)8
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer8
Attributable deaths of liver cancer in China8
Current status and perspectives of conversion therapy for advanced gastric cancer7
Laparoscopic vs. open surgery for gastrointestinal stromal tumors of esophagogastric junction: A multicenter, retrospective cohort analysis with propensity score weighting7
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road7
Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis7
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)7
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)7
0.050363063812256